Pathogenesis of Focal Segmental Glomerulosclerosis

키워드

참고문헌 (71)

1. D’Agati VD, "Pathologic classification of focal segmental glomerulosclerosis: a working proposal", Am J Kidney Dis, 43, pp.368~382 (2004)
2. Weiss MA, "Nephrotic syndrome, progressive irreversible renal failure, and glomerular “collapse”: a new clinicopathologic entity?", Am J Kidney Dis, 7, pp.20~28 (1986)
3. Moudgil A, "Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy", Kidney Int, 59, pp.2126~2133 (2001)
4. Markowitz GS, "Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate", J Am Soc Nephrol, 12, pp.1164~1172 (2001)
5. Markowitz GS, "Treatment with IFN-α, -β, or -γ is associated with collapsing focal segmental glomerulosclerosis", Clin J Am Soc Nephrol, 5, pp.607~615 (2010)
6. Mohamed N, "Collapsing glomerulopathy following anthracycline therapy", Am J Kidney Dis, 61, pp.778~781 (2013)
7. Gulati A, "Idiopathic collapsing glomerulopathy in children", Clin Exp Nephrol, 12, pp.348~353 (2008)
8. D’Agati VD, "Association of histologic variants in FSGS clinical trial with presenting features and outcomes", Clin J Am Soc Nephrol, 8, pp.399~406 (2013)
9. Trivedi M, "Tip variant of focal segmental glomerulosclerosis: is it truly a benign variant?", Ren Fail, 37, pp.763~768 (2015)
10. Kwon YE, "Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patients", BMC Nephrol, 15, pp.52~ (2014)
11. Paik KH, "Primary focal segmental glomerular sclerosis in children: clinical course and prognosis", Pediatr Nephrol, 22, pp.389~395 (2007)
12. Praditpornsilpa K, "Renal pathology and HIV infection in Thailand", Am J Kidney Dis, 33, pp.282~286 (1999)
13. Naaz I, "Collapsing glomerulopathy in an HIV-positive patient in a low-incidence belt", Indian J Nephrol, 20, pp.211~213 (2010)
14. Chang JW, "Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis", ransplantation, 93, pp.1238~1244 (2012)
15. Alachkar N, "Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy", Transplantation, 96, pp.649~656 (2013)
16. Canaud G, "Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS)", Nephrol Dial Transplant, 25, pp.1321~1328 (2010)
17. Matsusaka T, "Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury", J Am Soc Nephrol, 16, pp.1013~1023 (2005)
18. Wharram BL, "Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene", J Am Soc Nephrol, 16, pp.2941~2952 (2005)
19. Haas M, "Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis", Nephrol Dial Transplant, 13, pp.2013~2016 (1998)
20. Artero ML, "Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis", Am J Kidney Dis, 23, pp.574~581 (1994)
21. Savin VJ, "Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis", N Engl J Med, 334, pp.878~883 (1996)
22. Wei C, "Modification of kidney barrier function by the urokinase receptor", Nat Med, 14, pp.55~63 (2008)
23. Wei C, "Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis", Nat Med, 17, pp.952~960 (2011)
24. Wei C, "Circulating suPAR in two cohorts of primary FSGS", J Am Soc Nephrol, 23, pp.2051~2059 (2012)
25. Huang J, "Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis", Kidney Int, 84, pp.366~372 (2013)
26. Meijers B, "The soluble urokinase receptor is not a clinical marker for focal segmental glomerulosclerosis", Kidney Int, 85, pp.636~640 (2014)
27. Qin DD, "Plasma-soluble urokinase-type plasminogen activator receptor levels are associated with clinical and pathological activities in lupus nephritis: a large cohort study from China", Lupus, 24, pp.546~557 (2015)
28. Guo SM, "Soluble urokinase receptor levels are correlated with focal segmental glomerulosclerosis lesions in IgA nephropathy: a cohort study from China", PLoS One, 10, pp.e0138~ (2015)
29. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, "The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification", Kidney Int, 76, pp.534~545 (2009)
30. Savin VJ, "Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity", Transl Res, 151, pp.288~292 (2008)
31. McCarthy ET, "Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis", Clin J Am Soc Nephrol, 5, pp.2115~2121 (2010)
32. Sharma M, "Janus kinase 2", signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier, 2015, pp.166, 384~398
33. Trachtman H, "Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design", BMC Nephrol, 12, pp.8~ (2011)
34. Trachtman H, "Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group", BMC Nephrol, 16, pp.111~ (2015)
35. Clement LC, "Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome", Nat Med, 17, pp.117~122 (2011)
36. Clement LC, "Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome", Nat Med, 20, pp.37~46 (2014)
37. Chen YM, "Focal segmental glomerulosclerosis: molecular genetics and targeted therapies", BMC Nephrol, 16, pp.101~ (2015)
38. Jefferson JA, "The pathogenesis of focal segmental glomerulosclerosis", Adv Chronic Kidney Dis, 21, pp.408~416 (2014)
39. D'Agati VD, "Focal segmental glomerulosclerosis", N Engl J Med, 365, pp.2398~2411 (2011)
40. Pollak MR, "Familial FSGS", Adv Chronic Kidney Dis, 21, pp.422~425 (2014)
41. Kestilä M, "Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome", Mol Cell, 1, pp.575~582 (1998)
42. Boute N, "NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome", Nat Genet, 24, pp.349~354 (2000)
43. Hinkes B, "Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible", Nat Genet, 38, pp.1397~1405 (2006)
44. Mucha B, "Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9", Pediatr Res, 59, pp.325~331 (2006)
45. Zenker M, "Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities", Hum Mol Genet, 13, pp.2625~2632 (2004)
46. Ozaltin F, "Disruption of PTPRO causes childhood-onset nephrotic syndrome", Am J Hum Genet, 89, pp.139~147 (2011)
47. Gee HY, "ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling", J Clin Invest, 123, pp.3243~3253 (2013)
48. Ashraf S, "ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption", J Clin Invest, 123, pp.5179~5189 (2013)
49. Gee HY, "Mutations in EMP2 cause childhood-onset nephrotic syndrome", Am J Hum Genet, 94, pp.884~890 (2014)
50. Kaplan JM, "Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis", Nat Genet, 24, pp.251~256 (2000)
51. Winn MP, "A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis", Science, 308, pp.1801~1804 (2005)
52. Gigante M, "CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS)", Nephrol Dial Transplant, 24, pp.1858~1864 (2009)
53. Genovese G, "Association of trypanolytic ApoL1 variants with kidney disease in African Americans", Science, 329, pp.841~845 (2010)
54. Brown EJ, "Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis", Nat Genet, 42, pp.72~76 (2010)
55. Mele C, "MYO1E mutations and childhood familial focal segmental glomerulosclerosis", N Engl J Med, 365, pp.295~306 (2011)
56. Barua M, "Mutations in PAX2 associate with adult-onset FSGS", J Am Soc Nephrol, 25, pp.1942~1953 (2014)
57. Gbadegesin RA, "Mutations in the gene that encodes the F-actin binding protein anillin cause FSGS", J Am Soc Nephrol, 25, pp.1991~2002 (2014)
58. Ebarasi L, "Defects of CRB2 cause steroid-resistant nephrotic syndrome", Am J Hum Genet, 96, pp.153~161 (2015)
59. Wagner N, "The major podocyte protein nephrin is transcriptionally activated by the Wilms’ tumor suppressor WT1", J Am Soc Nephrol, 15, pp.3044~3051 (2004)
60. Hinkes BG, "Nephrotic syndrome in the first year of life: two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2)", Pediatrics, 119, pp.e907~e919 (2007)
61. Machuca E, "Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome", J Am Soc Nephrol, 21, pp.1209~1217 (2010)
62. Lee JH, "Genetic basis of congenital and infantile nephrotic syndromes", Am J Kidney Dis, 58, pp.1042~1043 (2011)
63. Appel D, "Recruitment of podocytes from glomerular parietal epithelial cells", J Am Soc Nephrol, 20, pp.333~343 (2009)
64. Ohse T, "A new function for parietal epithelial cells: a second glomerular barrier", Am J Physiol Renal Physiol, 297, pp.F1566~F1574 (2009)
65. Sagrinati C, "Isolation and characterization of multipotent progenitor cells from the Bowman’s capsule of adult human kidneys", J Am Soc Nephrol, 17, pp.2443~2456 (2006)
66. Ronconi E, "Regeneration of glomerular podocytes by human renal progenitors", J Am Soc Nephrol, 20, pp.322~332 (2009)
67. Lasagni L, "Glomerular epithelial stem cells: the good, the bad, and the ugly", J Am Soc Nephrol, 21, pp.1612~1619 (2010)
68. Smeets B, "Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells", J Am Soc Nephrol, 20, pp.2604~2615 (2009)
69. Smeets B, "Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis", J Am Soc Nephrol, 22, pp.1262~1274 (2011)
70. Smeets B, "Detection of activated parietal epithelial cells on the glomerular tuft distinguishes early focal segmental glomerulosclerosis from minimal change disease", Am J Pathol, 184, pp.3239~3248 (2014)
71. Fatima H, "Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant", Clin J Am Soc Nephrol, 7, pp.1852~1858 (2012)

관련 논문AI추천